CHF3,830.00
0.78% yesterday
SIX Swiss Exchange, Apr 04, 05:30 pm CET
ISIN
CH0010645932
Symbol
GIVN

Givaudan Target price 2025 - Analyst rating & recommendation

Givaudan Classifications & Recommendation:

Buy
35%
Hold
43%
Sell
22%

Givaudan Price Target

Target Price CHF4,231.10
Price CHF3,830.00
Potential 10.47%
Number of Estimates 21
21 Analysts have issued a price target Givaudan 2026 . The average Givaudan target price is CHF4,231.10. This is 10.47% higher than the current stock price. The highest price target is CHF5,100.00 33.16% , the lowest is CHF3,400.00 11.23% .
A rating was issued by 23 analysts: 8 Analysts recommend Givaudan to buy, 10 to hold and 5 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Givaudan stock has an average upside potential 2026 of 10.47% . Most analysts recommend the Givaudan stock at Hold.

Sales and Margin forecast 2025, 2026 to 2029


Dec '24 2025
Estimates
Revenue Billion CHF 7.41 7.81
7.19% 5.36%
EBITDA Margin 23.87% 24.18%
12.12% 1.31%
Net Margin 14.72% 14.86%
13.88% 0.98%

20 Analysts have issued a sales forecast Givaudan 2025 . The average Givaudan sales estimate is CHF7.8b . This is 5.36% higher than the revenue of the last 12 months(TTM). The highest sales forecast is CHF8.0b 7.39% , the lowest is CHF7.7b 3.64% .

This results in the following potential growth metrics:

Revenue Estimates

2024 CHF7.4b 7.19%
2025 CHF7.8b 5.36%
2026 CHF8.2b 4.84%
2027 CHF8.6b 5.07%
2028 CHF9.1b 5.59%
2029 CHF9.7b 6.92%

20 Analysts have issued an Givaudan EBITDA forecast 2025. The average Givaudan EBITDA estimate is CHF1.9b . This is 6.75% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is CHF1.9b 9.50% , the lowest is CHF1.7b 5.91% .

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 CHF1.8b 20.18%
2025 CHF1.9b 6.75%
2026 CHF2.0b 4.94%
2027 CHF2.4b 19.59%
2028 CHF2.1b 9.38%
2029 CHF2.2b 1.44%

EBITDA Margin

2024 23.87% 12.12%
2025 24.18% 1.31%
2026 24.20% 0.08%
2027 27.55% 13.84%
2028 23.64% 14.19%
2029 22.43% 5.12%

14 Givaudan Analysts have issued a net profit forecast 2025. The average Givaudan net profit estimate is CHF1.2b . This is 6.40% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is CHF1.2b 11.22% , the lowest is CHF1.1b 1.82% .

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 CHF1.1b 22.06%
2025 CHF1.2b 6.40%
2026 CHF1.3b 8.45%
2027 CHF1.8b 43.31%
2028 CHF1.4b 23.83%
2029 CHF1.4b 1.35%

Net Margin

2024 14.72% 13.88%
2025 14.86% 0.98%
2026 15.37% 3.43%
2027 20.97% 36.43%
2028 15.13% 27.85%
2029 14.34% 5.22%

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029


Dec '24 2025
Estimates
Earnings Per Share CHF 118.17 125.74
22.06% 6.41%
P/E 30.46
EV/Sales 5.04

14 Analysts have issued a Givaudan forecast for earnings per share. The average Givaudan EPS is CHF125.74 . This is 6.41% higher than earnings per share in the financial year 2024. The highest EPS forecast is CHF131.43 11.22% , the lowest is CHF116.02 1.82% .

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 CHF118.17 22.06%
2025 CHF125.74 6.41%
2026 CHF136.36 8.45%
2027 CHF195.41 43.30%
2028 CHF148.85 23.83%
2029 CHF150.87 1.36%

P/E ratio

Current 32.41 21.87%
2025 30.46 6.02%
2026 28.09 7.78%
2027 19.60 30.22%
2028 25.73 31.28%
2029 25.39 1.32%

Based on analysts' sales estimates for 2025, the Givaudan stock is valued at an EV/Sales of 5.04 and an P/S ratio of 4.53 .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 5.31 11.20%
2025 5.04 5.16%
2026 4.80 4.62%
2027 4.57 4.83%
2028 4.33 5.29%
2029 4.05 6.47%

P/S ratio

Current 4.77 11.04%
2025 4.53 5.09%
2026 4.32 4.62%
2027 4.11 4.83%
2028 3.89 5.30%
2029 3.64 6.47%

Current Givaudan Upgrades & Downgrades

Analyst Rating Action Date
RESEARCH PARTNERS AG
Hold
Buy
Upgrade Jan 06 2025
BNP PARIBAS EXANE
Neutral
Neutral
Unchanged Jan 05 2025
BAADER HELVEA EQUITY RESEARCH
Buy
Buy
Unchanged Dec 16 2024
BERENBERG
Hold
Hold
Unchanged Dec 08 2024
STIFEL EUROPE
Hold
Hold
Unchanged Nov 07 2024
DZ BANK
Hold
Hold
Unchanged Oct 16 2024
REDBURN ATLANTIC
Neutral
Neutral
Unchanged Oct 10 2024
Analyst Rating Date
Upgrade
RESEARCH PARTNERS AG:
Hold
Buy
Jan 06 2025
Unchanged
BNP PARIBAS EXANE:
Neutral
Neutral
Jan 05 2025
Unchanged
BAADER HELVEA EQUITY RESEARCH:
Buy
Buy
Dec 16 2024
Unchanged
BERENBERG:
Hold
Hold
Dec 08 2024
Unchanged
STIFEL EUROPE:
Hold
Hold
Nov 07 2024
Unchanged
DZ BANK:
Hold
Hold
Oct 16 2024
Unchanged
REDBURN ATLANTIC:
Neutral
Neutral
Oct 10 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today